Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial

Kiromic BioPharma, Inc. reports early efficacy results showing tumor stabilization in the third patient enrolled in the Companyโ€™s Deltacel-01 Phase 1 clinical trial. Deltacel-01 is evaluating Deltacelโ„ข (KB-GDT-01), Kiromicโ€™s allogeneic....

Nested Therapeutics Receives FDA Clearance for IND Application of NST-628, a Groundbreaking Pan-RAF/MEK Molecular Glue

Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND)....

Akebia's Vafseoยฎ (vadadustat) Tablets FDA Approved for Anemia Treatment in Dialysis Patients

Akebia Therapeuticsยฎ, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseoยฎ (vadadustat)....

Trailblazing 3D human liver models yield accurate MASH phenotype

Viscient Biosciences ("Viscient") announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a...

Octapharma Announces Availability of Balfaxarยฎ For Warfarin Reversal in Urgent Surgery & Invasive Procedures

Octapharma USA has announced Balfaxarยฎ (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplexยฎ) is now available. The new non-activated four factor prothrombin complex concentrate (4F-PCC), approved by the U.S....